The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zhu, F.-G.
Right arrow Articles by Marshall, J. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zhu, F.-G.
Right arrow Articles by Marshall, J. S.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*CYCLOPENTANE
*MONENSIN
The Journal of Immunology, 1998, 161: 2541-2551.
Copyright © 1998 by The American Association of Immunologists

Short-Term and Long-Term Cytokine Release by Mouse Bone Marrow Mast Cells and the Differentiated KU-812 Cell Line Are Inhibited by Brefeldin A1

Fu-Gang Zhu, Kaede Gomi and Jean S. Marshall2

Departments of Microbiology and Immunology and Pathology, Dalhousie University, Halifax, Nova Scotia, Canada

Mast cells and basophils produce a wide range of cytokines, including large amounts of both IL-6 and granulocyte-macrophage CSF (GM-CSF). However, the route by which cytokines are secreted is poorly understood. In the current study, we used two inhibitors of vesicular transport, brefeldin A and monensin, to examine the routes of secretion of IL-6 and GM-CSF in the differentiated KU812 human cell line and cultured mouse bone marrow mast cells (mBMMC). Studies of cytokine production over 6 to 24 h demonstrated that IL-6 and GM-CSF release from both cell types were inhibited by brefeldin A (BFA) following activation with calcium ionophore, A23187. Monensin had similar inhibitory effects to that of BFA on the initial and ongoing IL-6 release from KU812 cells. In contrast, the amount of each cytokine remaining within the cells was significantly enhanced. Similar results were obtained following IgE-mediated activation of mBMMC. BFA significantly inhibited both the constitutive secretion of IL-6 and the immediate ionophore-induced increase in IL-6 release from KU812 cells at 20 min postactivation. However, treatment with these agents did not alter the release of histamine and ß-hexaminidase from either mBMMC or KU812 cells. These studies suggest that both the initial 20-min release of IL-6 and secretion of IL-6 and GM-CSF over up to 24 h by mBMMC and differentiated KU-812 cells occur predominately through a vesicular transport-dependent mechanism, and that little, if any, IL-6 and GM-CSF is released through degranulation.




This article has been cited by other articles:


Home page
J. Immunol.Home page
M. Watanabe, T. Satoh, Y. Yamamoto, Y. Kanai, H. Karasuyama, and H. Yokozeki
Overproduction of IgE Induces Macrophage-Derived Chemokine (CCL22) Secretion from Basophils
J. Immunol., October 15, 2008; 181(8): 5653 - 5659.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
I. Ikonomidis, G. Athanassopoulos, J. Lekakis, K. Venetsanou, M. Marinou, K. Stamatelopoulos, D. V. Cokkinos, and P. Nihoyannopoulos
Myocardial Ischemia Induces Interleukin-6 and Tissue Factor Production in Patients With Coronary Artery Disease: A Dobutamine Stress Echocardiography Study
Circulation, November 22, 2005; 112(21): 3272 - 3279.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
Y.-N. Lee, J. Tuckerman, H. Nechushtan, G. Schutz, E. Razin, and P. Angel
c-Fos as a Regulator of Degranulation and Cytokine Production in Fc{epsilon}RI-Activated Mast Cells
J. Immunol., August 15, 2004; 173(4): 2571 - 2577.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
K. Kandere-Grzybowska, R. Letourneau, D. Kempuraj, J. Donelan, S. Poplawski, W. Boucher, A. Athanassiou, and T. C. Theoharides
IL-1 Induces Vesicular Secretion of IL-6 without Degranulation from Human Mast Cells
J. Immunol., November 1, 2003; 171(9): 4830 - 4836.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
T. Kumamoto, D. Shalhevet, H. Matsue, M. E. Mummert, B. R. Ward, J. V. Jester, and A. Takashima
Hair follicles serve as local reservoirs of skin mast cell precursors
Blood, September 1, 2003; 102(5): 1654 - 1660.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
P. Forsythe and A. D. Befus
Inhibition of Calpain Is a Component of Nitric Oxide-Induced Down-Regulation of Human Mast Cell Adhesion
J. Immunol., January 1, 2003; 170(1): 287 - 293.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
F.-G. Zhu and J. S. Marshall
CpG-containing oligodeoxynucleotides induce TNF-{alpha} and IL-6 production but not degranulation from murine bone marrow-derived mast cells
J. Leukoc. Biol., February 1, 2001; 69(2): 253 - 262.
[Abstract] [Full Text]


Home page
J. Immunol.Home page
K. Gomi, F.-G. Zhu, and J. S. Marshall
Prostaglandin E2 Selectively Enhances the IgE-Mediated Production of IL-6 and Granulocyte-Macrophage Colony-Stimulating Factor by Mast Cells Through an EP1/EP3-Dependent Mechanism
J. Immunol., December 1, 2000; 165(11): 6545 - 6552.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
C. A. King, J. S. Marshall, H. Alshurafa, and R. Anderson
Release of Vasoactive Cytokines by Antibody-Enhanced Dengue Virus Infection of a Human Mast Cell/Basophil Line
J. Virol., August 1, 2000; 74(15): 7146 - 7150.
[Abstract] [Full Text]


Home page
J. Immunol.Home page
T.-J. Lin, T. B. Issekutz, and J. S. Marshall
Human Mast Cells Transmigrate Through Human Umbilical Vein Endothelial Monolayers and Selectively Produce IL-8 in Response to Stromal Cell-Derived Factor-1{alpha}
J. Immunol., July 1, 2000; 165(1): 211 - 220.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
H. Nechushtan, M. Leitges, C. Cohen, G. Kay, and E. Razin
Inhibition of degranulation and interleukin-6 production in mast cells derived from mice deficient in protein kinase Cbeta
Blood, March 1, 2000; 95(5): 1752 - 1757.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1998 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1998 by The American Association of Immunologists, Inc. All rights reserved.